New weekly shot helps shed pounds in obesity trial
NCT ID NCT06595238
First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 2 times
Summary
This study tested a new medicine called AZD6234, given as a weekly shot, to help people with obesity or overweight lose weight. About 262 adults took part for 36 weeks. The goal was to see if the drug leads to greater weight loss compared to a placebo, especially for those with weight-related health problems like high blood pressure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
Mobile, Alabama, 36608, United States
-
Research Site
Phoenix, Arizona, 85044, United States
-
Research Site
Long Beach, California, 90815, United States
-
Research Site
Hialeah, Florida, 33012, United States
-
Research Site
Largo, Florida, 33777, United States
-
Research Site
Orlando, Florida, 32825, United States
-
Research Site
Tampa, Florida, 33606, United States
-
Research Site
Woodstock, Georgia, 30189, United States
-
Research Site
Indianapolis, Indiana, 46260, United States
-
Research Site
Lutherville-Timonium, Maryland, 21093, United States
-
Research Site
Gulfport, Mississippi, 39503, United States
-
Research Site
Ridgeland, Mississippi, 39157, United States
-
Research Site
Kansas City, Missouri, 64111, United States
-
Research Site
Omaha, Nebraska, 68134, United States
-
Research Site
Portsmouth, New Hampshire, 03801, United States
-
Research Site
Statesville, North Carolina, 28625, United States
-
Research Site
North Charleston, South Carolina, 29405, United States
-
Research Site
Knoxville, Tennessee, 37938, United States
-
Research Site
Austin, Texas, 78731, United States
-
Research Site
Dallas, Texas, 75230, United States
-
Research Site
Port Arthur, Texas, 77642, United States
-
Research Site
San Antonio, Texas, 78231, United States
-
Research Site
San Antonio, Texas, 78249, United States
-
Research Site
Heidelberg, 3081, Australia
-
Research Site
Maroochydore, 4556, Australia
-
Research Site
Maroubra, 2035, Australia
-
Research Site
Merewether, 2291, Australia
-
Research Site
Hamilton, Ontario, L8L 5G8, Canada
-
Research Site
Sarnia, Ontario, N7T 4X3, Canada
-
Research Site
Stouffville, Ontario, L4A1H2, Canada
-
Research Site
Toronto, Ontario, M3J 0K2, Canada
-
Research Site
Montreal, Quebec, H4N 2W2, Canada
-
Research Site
Sherbrooke, Quebec, J1L 0H8, Canada
-
Research Site
Chūōku, 103-0027, Japan
-
Research Site
Chūōku, 104-0031, Japan
-
Research Site
Shinjuku-ku, 160-0008, Japan
-
Research Site
Suita-shi, 565-0853, Japan
-
Research Site
Hull, HU3 2PA, United Kingdom
-
Research Site
Leicester, Le5 4PW, United Kingdom
-
Research Site
Penarth, CF64 2XX, United Kingdom
-
Research Site
Rotherham, S65 1DA, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?